Market Place
Sourcing Support
Go or no go? Esperion`s double whammy and a look to priority reviews
31 Jan 2020 //
EVALUATE
Acacia Pharma enters into strategic in-licensing, investment
10 Jan 2020 //
GLOBE NEWSWIRE
GHO Capital Acquires Ardena, a Leading CDMO
09 Jan 2020 //
BUSINESS WIRE
Acacia eyes February FDA verdict for refiled nausea drug Barhemsys
27 Sep 2019 //
PMLIVE
Second CRL given to Acacia after ‘continuing deficiencies’
08 May 2019 //
IN-PHARMATECHNOLOGIST
FDA rejects Acacia’s lead drug — again — due to the same manufacturing issue
04 May 2019 //
ENDPTS
Ofloxacin - List of nationally authorised medicinal products
11 Dec 2018 //
EMA
Acacia’s PONV drug under US review
08 Jan 2018 //
PHARMA TIMES
Former Pfizer, Sanofi and Acacia execs on the move
22 Nov 2017 //
Acacia Pharma announces +ve result from PIII study of Baremsis to treat PONV
15 Aug 2016 //
PHARMABIZ
Global Drugs Market 2015-2019 with GSK,Helsinn,Heron,Merck & Tesaro Dominating
04 Nov 2015 //
PR NEWS WIRE
Biocon buys Acacia`s API unit in Vizag
02 Oct 2015 //
ETHEALTHWORLD
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.